{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:13:49Z","timestamp":1788930829188,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS051709-14"],"award-info":[{"award-number":["R01NS051709-14"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FI 2138\/1-1"],"award-info":[{"award-number":["FI 2138\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbi.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T09:03:01Z","timestamp":1560762181000},"page":"247-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis"],"prefix":"10.1016","volume":"81","author":[{"given":"Roman","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Padutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Bracchi-Ricard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George.F.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niky","family":"Delguercio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Elmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Sendetski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich L.M.","family":"Eisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Smeyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland E.","family":"Kontermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pfizenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Bethea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.06.021_b0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0010","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0015","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.1807499115","article-title":"Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity","volume":"115","author":"Atretkhany","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.06.021_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03033380","article-title":"Axonal degeneration and progressive neurologic disability in multiple sclerosis","volume":"5","author":"Bjartmar","year":"2003","journal-title":"Neurotox Res."},{"key":"10.1016\/j.bbi.2019.06.021_b0025","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2019.06.021_b0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/j.pain.0000000000001483","article-title":"Sex differences in central nervous system plasticity and pain in experimental autoimmune encephalomyelitis","volume":"160","author":"Catuneanu","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.06.021_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0040","doi-asserted-by":"crossref","first-page":"32834","DOI":"10.1038\/srep32834","article-title":"TNFR2 expression by CD4 effector T cells is required to induce full-fledged experimental colitis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2019.06.021_b0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/eji.200940022","article-title":"Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood","volume":"40","author":"Chen","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0055","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1084\/jem.20151563","article-title":"Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion","volume":"213","author":"Chopra","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2019.06.021_b0060","doi-asserted-by":"crossref","first-page":"14415","DOI":"10.1523\/JNEUROSCI.4569-09.2009","article-title":"T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity","volume":"29","author":"Costigan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbi.2014.04.003","article-title":"Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling","volume":"41","author":"Dellarole","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.06.021_b0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nn.4528","article-title":"Regulatory T cells promote myelin regeneration in the central nervous system","volume":"20","author":"Dombrowski","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0075","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.1605195113","article-title":"Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration","volume":"113","author":"Dong","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2019.06.021_b0080","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1815-18.2019","article-title":"Regulatory T cells and their derived cytokine, interleukin-35, reduce pain in experimental autoimmune encephalomyelitis","author":"Duffy","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2016.00369","article-title":"Peripheral and central neuroinflammatory changes and pain behaviors in an animal model of multiple sclerosis","volume":"7","author":"Duffy","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/antib4010048","article-title":"Targeting sTNF\/TNFR1 signaling as a new therapeutic strategy","volume":"4","author":"Fischer","year":"2015","journal-title":"Antibodies"},{"key":"10.1016\/j.bbi.2019.06.021_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/610813","article-title":"Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF","volume":"2015","author":"Fischer","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbi.2019.06.021_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027621","article-title":"A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death","volume":"6","author":"Fischer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.06.021_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/art.40413","article-title":"Selective activation of tumor necrosis factor receptor 2 induces anti-inflammatory responses and alleviates experimental arthritis","author":"Fischer","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbi.2019.06.021_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/glia.22605","article-title":"Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor","volume":"62","author":"Fischer","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2019.06.021_b0115","doi-asserted-by":"crossref","first-page":"RC216","DOI":"10.1523\/JNEUROSCI.22-07-j0001.2002","article-title":"Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2","volume":"22","author":"Fontaine","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.celrep.2016.11.083","article-title":"Opposing functions of microglial and macrophagic TNFR2 in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"18","author":"Gao","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2019.06.021_b0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.170.2.607","article-title":"Tumor necrosis factor identified in multiple sclerosis brain","volume":"170","author":"Hofman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2019.06.021_b0135","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.1700346","article-title":"T cell-transfer experimental autoimmune encephalomyelitis: pillar of multiple sclerosis and autoimmunity","volume":"198","author":"Hohlfeld","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410140313","article-title":"Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions","volume":"14","author":"Itoyama","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2019.06.021_b0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2019.06.021_b0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group","volume":"53","author":"Lenercept Study Group","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2019.06.021_b0150","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1523\/JNEUROSCI.0211-16.2016","article-title":"Oligodendroglial TNFR2 mediates membrane tnf-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination","volume":"36","author":"Madsen","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2013.09.083","article-title":"TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress","volume":"440","author":"Maier","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2019.06.021_b0160","doi-asserted-by":"crossref","first-page":"32869","DOI":"10.1074\/jbc.M311766200","article-title":"Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway","volume":"279","author":"Marchetti","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.06.021_b0165","article-title":"TNF activity and T cells","author":"Mehta","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2019.06.021_b0170","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.1500286","article-title":"Transmembrane TNF-TNFR2 Impairs Th17 differentiation by promoting Il2 expression","volume":"195","author":"Miller","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0180","unstructured":"Murphy, K.L., Bethea, J.R., Fischer, R., 2017. Neuropathic Pain in Multiple Sclerosis-Current Therapeutic Intervention and Future Treatment Perspectives. In: Zagon, I.S., McLaughlin, P.J. (Eds.), Multiple Sclerosis: Perspectives in Treatment and Pathogenesis, Brisbane (AU)."},{"key":"10.1016\/j.bbi.2019.06.021_b0185","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/srep03153","article-title":"Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2","volume":"3","author":"Okubo","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2019.06.021_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnins.2019.00049","article-title":"Targeting TNFR2 as a novel therapeutic strategy for Alzheimer's disease","volume":"13","author":"Orti-Casan","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0195","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00401-012-1034-0","article-title":"Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS","volume":"124","author":"Patel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2019.06.021_b0200","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fimmu.2018.00925","article-title":"Selective modulation of TNF-TNFRs signaling: insights for multiple sclerosis treatment","volume":"9","author":"Pegoretti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2019.06.021_b0210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mrd.22489","article-title":"The ImageJ ecosystem: an open platform for biomedical image analysis","volume":"82","author":"Schindelin","year":"2015","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.bbi.2019.06.021_b0215","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","article-title":"Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis","volume":"325","author":"Sharief","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2019.06.021_b0220","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.2000.1706","article-title":"Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35\u201355)-induced experimental autoimmune encephalomyelitis","volume":"205","author":"Suvannavejh","year":"2000","journal-title":"Cell Immunol."},{"key":"10.1016\/j.bbi.2019.06.021_b0230","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/brain\/awr203","article-title":"Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB","volume":"134","author":"Taoufik","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2019.06.021_b0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/j.pain.0000000000000409","article-title":"Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis","volume":"157","author":"Thorburn","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.06.021_b0240","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2019.06.021_b0245","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mcn.2010.06.014","article-title":"Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways","volume":"45","author":"Veroni","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2019.06.021_b0250","doi-asserted-by":"crossref","first-page":"42304","DOI":"10.1038\/srep42304","article-title":"Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2019.06.021_b0255","doi-asserted-by":"crossref","first-page":"13628","DOI":"10.1038\/s41598-018-31957-7","article-title":"Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis","volume":"8","author":"Williams","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2019.06.021_b0260","article-title":"Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis","volume":"9","author":"Williams","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.06.021_b0265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2018.00583","article-title":"The significance of tumor necrosis factor receptor type II in CD8(+) regulatory T Cells and CD8(+) effector T cells","volume":"9","author":"Ye","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:22:26Z","timestamp":1777576946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119303782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":53,"alternative-id":["S0889159119303782"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.06.021","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}